"Cyclopropanes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
Descriptor ID |
D003521
|
MeSH Number(s) |
D02.455.426.392.368.533
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cyclopropanes".
Below are MeSH descriptors whose meaning is more specific than "Cyclopropanes".
This graph shows the total number of publications written about "Cyclopropanes" by people in this website by year, and whether "Cyclopropanes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 2 | 2 |
2015 | 0 | 2 | 2 |
2016 | 1 | 0 | 1 |
2017 | 3 | 39 | 42 |
2018 | 1 | 49 | 50 |
2019 | 0 | 14 | 14 |
2020 | 2 | 3 | 5 |
2021 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Cyclopropanes" by people in Profiles.
-
Montelukast and Coronavirus Disease 2019: A Scoping Review. Iran J Allergy Asthma Immunol. 2021 Aug 07; 20(4):384-393.
-
Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19. Pharmacology. 2021; 106(9-10):469-476.
-
Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight. Biochem Biophys Res Commun. 2021 09 24; 571:26-31.
-
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. Eur J Pharmacol. 2021 Aug 05; 904:174196.
-
Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase. Sci Rep. 2021 05 13; 11(1):10290.
-
Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir. Sci Rep. 2021 03 31; 11(1):7307.
-
Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment. J Comput Chem. 2021 05 15; 42(13):897-907.
-
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
-
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
-
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico. Int J Infect Dis. 2021 Apr; 105:598-605.